Overview

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

Status:
Not yet recruiting

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

This study will investigate if a medication (metformin) widely used in the treatment of diabetes could be re-purposed for the treatment of patients with a diagnosis of early stage ADPKD to slow the growth of kidney cysts, thereby slowing the rate of kidney function decline, reducing morbidity and mortality and improving the quality of life for ADPKD patients.

Phase:

Phase 3

Details

Lead Sponsor:

The University of Queensland

Treatments:

Metformin